These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19762786)

  • 41. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation.
    Chang SA; Lee EJ; Kang HJ; Zhang SY; Kim JH; Li L; Youn SW; Lee CS; Kim KH; Won JY; Sohn JW; Park KW; Cho HJ; Yang SE; Oh WI; Yang YS; Ho WK; Park YB; Kim HS
    Stem Cells; 2008 Jul; 26(7):1901-12. PubMed ID: 18403756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation.
    Wolf D; Reinhard A; Seckinger A; Gross L; Katus HA; Hansen A
    Scand Cardiovasc J; 2009 Feb; 43(1):39-45. PubMed ID: 18609048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
    Ma DC; Yang ZJ; Wang W; Xu SL; Zhang YQ; Zhou F; Chen B; Xu ZQ; Cao KJ; Ma WZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):119-22. PubMed ID: 16626576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair.
    Shujia J; Haider HK; Idris NM; Lu G; Ashraf M
    Cardiovasc Res; 2008 Feb; 77(3):525-33. PubMed ID: 18032392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.
    Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound-mediated microbubble destruction enhances the efficacy of bone marrow mesenchymal stem cell transplantation and cardiac function.
    Song X; Zhu H; Jin L; Wang J; Yang Q; Jin P; Li X
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):267-71. PubMed ID: 18785979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [MR imaging of injected magnetically labeled stem cells in myocardial infarction: experiment with pigs].
    Qi CM; Ma GS; Liu NF; Chen Z; Shen CX; Liu XJ; Hu YP; Su YM; Li X; Teng GJ; Ju SH; Zhang XL; Gu N
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1523-6. PubMed ID: 17785100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mid-term effect of stem cells combined with transmyocardial degradable stent on swine model of acute myocardial infarction.
    Luan Y; Liu XC; Zhang GW; Shi RF; Zhao XB; Zhao CH; Liu TJ; Lü F; Yang Q; He GW
    Coron Artery Dis; 2010 Jun; 21(4):233-43. PubMed ID: 20375694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Autologus bone marrow-derived mesenchymal stem cells intracoronary delivery after acute myocardial infarction in miniature pig].
    Yin CQ; Chen JL; Wang YF; Cao F; Cheng R; Pei XT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):696-9. PubMed ID: 16447640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source.
    Zhang S; Ge J; Sun A; Xu D; Qian J; Lin J; Zhao Y; Hu H; Li Y; Wang K; Zou Y
    J Cell Biochem; 2006 Nov; 99(4):1132-47. PubMed ID: 16795039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site.
    Mäkelä J; Ylitalo K; Lehtonen S; Dahlbacka S; Niemelä E; Kiviluoma K; Rimpiläinen J; Alaoja H; Paavonen T; Lehenkari P; Juvonen T; Anttila V
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):565-73. PubMed ID: 17723800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
    Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction.
    Armiñán A; Gandía C; García-Verdugo JM; Lledó E; Trigueros C; Ruiz-Saurí A; Miñana MD; Solves P; Payá R; Montero JA; Sepúlveda P
    J Am Coll Cardiol; 2010 May; 55(20):2244-53. PubMed ID: 20466205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction.
    Guo J; Lin G; Bao C; Hu Z; Chu H; Hu M
    J Biomed Sci; 2008 Jan; 15(1):89-97. PubMed ID: 17805990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.
    Grinnemo KH; Månsson A; Dellgren G; Klingberg D; Wardell E; Drvota V; Tammik C; Holgersson J; Ringdén O; Sylvén C; Le Blanc K
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1293-300. PubMed ID: 15115985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of different routes of administration of heterologous 5-azacytidine-treated mesenchymal stem cells in a porcine model of myocardial infarction.
    Moscoso I; Barallobre J; de Ilarduya OM; Añón P; Fraga M; Calviño R; Aldama G; Doménech N
    Transplant Proc; 2009; 41(6):2273-5. PubMed ID: 19715895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.